Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 USD | +8.89% |
|
-21.57% | -14.41% |
Jun. 24 | Aridis Pharmaceuticals, Inc. Provides Corporate Update on Recent Developments | CI |
Jun. 24 | Aridis Pharmaceuticals, Inc. announced that it expects to receive $0.299 million in funding | CI |
Financials (USD)
Sales 2021 | 1.54M | Sales 2022 | 3.09M | Capitalization | 29.39M |
---|---|---|---|---|---|
Net income 2021 | -42M | Net income 2022 | -30M | EV / Sales 2021 | 13.4 x |
Net cash position 2021 | 12.12M | Net Debt 2022 | 1.25M | EV / Sales 2022 | 9.91 x |
P/E ratio 2021 |
-0.62
x | P/E ratio 2022 |
-0.73
x | Employees | 37 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 81.95% |
1 day | +8.89% | ||
1 week | -21.57% | ||
Current month | +20.48% | ||
1 month | +3.27% | ||
3 months | -16.32% | ||
6 months | -19.79% | ||
Current year | -14.41% |
![Extreme 0.045](/images/extremecours_fleche.png)
![Extreme 0.0312](/images/extremecours_fleche.png)
![Extreme 0.0312](/images/extremecours_fleche.png)
![Extreme 0.0312](/images/extremecours_fleche.png)
![Extreme 0.0312](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Vu Truong
CEO | Chief Executive Officer | 60 | 02-12-31 |
Eric Patzer
FOU | Founder | 75 | 02-12-31 |
Tamara Allen
DFI | Director of Finance/CFO | 57 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Hamilton
BRD | Director/Board Member | 79 | 15-03-31 |
Eric Patzer
FOU | Founder | 75 | 02-12-31 |
Vu Truong
CEO | Chief Executive Officer | 60 | 02-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-12 | 0.06 | +8.89% | 248,779 |
24-07-11 | 0.0551 | -17.58% | 152,688 |
24-07-10 | 0.0668 | -4.50% | 44,426 |
24-07-09 | 0.07 | -1.41% | 66,782 |
24-07-08 | 0.071 | -7.19% | 20,921 |
Delayed Quote OTC Markets, July 12, 2024 at 02:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-14.41% | 3.2M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- ARDS Stock